Lifecore Biomedical, Inc. De (LFCR) Other financing activities (2010 - 2025)

Lifecore Biomedical has reported Other financing activities for 10 years, with the latest figure at -$888000.0 in Q2 2025.

• On a quarterly basis, Other financing activities changed N/A year-over-year to -$888000.0 in Q2 2025; TTM through May 2025 was -$1.5 million, a 312.29% decrease from a year earlier, with the FY2024 full-year figure at $724000.0, changed N/A from the prior year.
• Other financing activities was -$888000.0 for Q2 2025 at Lifecore Biomedical, down from -$649000.0 in the prior quarter.
• The five-year high for Other financing activities was $724000.0 in Q3 2023, with the low at -$4.8 million in Q2 2023.
• Average Other financing activities over 3 years is -$939166.7, with a median of -$325000.0 recorded in 2024.
• The largest YoY upside for Other financing activities was 99.86% in 2024 against a maximum downside of 99.86% in 2024.
• Over 3 years, Other financing activities stood at $724000.0 in 2023, then sank by 100.14% to -$1000.0 in 2024, then sank by 88700.0% to -$888000.0 in 2025.
• The last three Other financing activities figures came in at -$888000.0 (Q2 2025), -$649000.0 (Q1 2025), and -$1000.0 (Q4 2024), per Business Quant data.